secwatch.observer — SEC 8-K summary
======================================

Issuer:     Indivior Pharmaceuticals, Inc. (INDV)
CIK:        0001625297
Form:       8-K
Filed at:   2025-11-20T23:59:59+00:00
Accession:  0001625297-25-000069
Event type: regulatory
Sentiment:  positive
Materiality: 0.75
Item codes: 1.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Indivior pays $295M to DOJ, concludes legacy resolution agreement
-----------------------------------------------------------------

- Paid $295M in full to DOJ using cash on hand, resolving 2020 Resolution Agreement.
- Resolution Agreement terminated on November 20, 2025.
- CEO Joe Ciaffoni says milestone removes significant liability and simplifies capital structure.
- Company reaffirms commitment to compliance and transparency.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1625297/000162529725000069/0001625297-25-000069-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1625297/000162529725000069/indv-20251120.htm
  HTML page:      https://secwatch.observer/filing/0001625297-25-000069

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer